glp-1 agonists tirzepatide Semaglutide & are transforming diabetes & obesity management. These receptor offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from The GLP-1 Powerhouses: Semaglutide vs.

Cerebrospinal fluid concentration of complement component 4a is increased in first episode schizophrenia

Its role as a fat transporter supports metabolic engagement by mobilizing stored fat for energy use, potentially supporting patients in developing leaner physiques over time when combined with appropriate diet and exercise

While these medications are not primarily classified as hormonal therapies, their metabolic effects inevitably intersect with endocrine function, particularly in patients with obesity and insulin resistanceconditions known to disrupt multiple hormonal axes

LigPlot+: multiple ligandprotein interaction diagrams for drug discovery